Lennham Pharmaceuticals, Inc.
CONCORD, MA · Founded 2019 · CIK 0001853301 · Biotech · Private
Deuterium-substituted pharmaceutical compounds
lennham.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $3.5M
- 2 Form D · Apr 2023
- 42 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 12 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,325,000 | |
| Private capital raised | Form D · SEC | $1,200,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2319 | INMUNE BIO, INC. | — | $8.0M |
| 2320 | ARUKA BIO, INC. | — | $3.6M |
| 2321 | Genomics PLC | — | — |
| 2322 | Lennham Pharmaceuticals, Inc. | — | $3.5M |
| 2323 | SUS CLINICALS INC | — | $3.5M |
| 2324 | Myricx Bio | — | — |
| 2325 | Abiologics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Benjamin EnersonExecutive Officer
- Corey MacGregorExecutive Officer
- Bradford SippyDirector · Executive Officer
Patents
- Deuterated Caffeine And Uses Thereofapplication
- D9-CAFFEINE Compositions And Uses Thereofgranted
- Products Comprising Deuterium-enriched Waterapplication
- Deuterated Forms Of Testosterone And Methods Of Usegranted
- Deuterated Caffeine And Uses Thereofapplication
- Deuterated Derivatives Of Psilocybin And Uses Thereofapplication
- Deuterated Forms Of Testosterone And Methods Of Useapplication
- Deuterated Caffeine And Uses Thereofapplication
- Deuterated Paraxanthine And Uses Thereofapplication
- Deuterated Caffeine And Uses Thereofgranted
- Deuterated Forms Of Acetaminophen And Uses Thereofgranted
- Method Of Treatment Based On Reduced Monoamine Oxidase A Activityapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.